Ignite Creation Date:
2025-12-25 @ 12:58 AM
Ignite Modification Date:
2026-03-02 @ 7:44 AM
Study NCT ID:
NCT01978093
Status:
COMPLETED
Last Update Posted:
2018-09-14
First Post:
2013-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-01
Start Date Type:
None
Primary Completion Date:
2016-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-31
First Submit QC Date:
None
Study First Post Date:
2013-11-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-28
Results First Submit QC Date:
None
Results First Post Date:
2018-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-01-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-08-16
Last Update Post Date:
2018-09-14
Last Update Post Date Type:
ACTUAL